<DOC>
	<DOCNO>NCT00693251</DOCNO>
	<brief_summary>It unclear stenting strategy optimal true bifurcation coronary lesion .</brief_summary>
	<brief_title>Optimal Stenting Strategy For True Bifurcation Lesions</brief_title>
	<detailed_description>The outcome percutaneous coronary intervention bifurcation lesion bare-metal stent hinder increase rate procedural complication long-term major adverse cardiac event compare non-bifurcated lesions.1 Randomized study demonstrate drug-eluting stent reduce restenosis use relatively simple lesion ; recent data demonstrate efficacy sirolimus-eluting stent bifurcation lesion compare historical data BMS . In one study bifurcation lesion , overall restenosis rate 23 % , majority side branch restenoses occur ostium use T-stenting technique . Indeed , side branch restenosis occur 16.7 % T-stenting , compare 7.1 % stenting technique . The `` crush '' technique bifurcation stenting DESs introduce Colombo et al . 2003 relatively simple technique ensure complete coverage side branch ostium , thereby facilitate drug delivery site . Initial data 20 patient treat technique SES suggest safe method , acceptable rate procedural complication adverse event 30 day follow-up . Recently , angiographic data show importance simultaneous kiss balloon post-dilation reduce restenosis need target lesion revascularization . They also report compare T-stenting , crush final kissing balloon dilatation associate low rate restenosis target lesion revascularization . Consequently , crush currently promise technique treat bifurcation lesion use two stent . However , despite advance bifurcation stenting technique , superiority bifurcation stenting crush technique simple stenting bifurcation lesion demonstrate . Therefore , conduct prospective randomize study compare crush technique final kissing balloon dilatation simple technique ( main vessel stenting provisional T-stenting ) treatment true bifurcation lesion .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Clinical Patients angina document ischemia patient document silent ischemia Patients eligible intracoronary stenting Age &gt; 18 year , &lt; 75 age Angiographic De novo lesion locate major bifurcation point MEDINA classification type 1.1.0 , 1.0.0 , 0.1.0 Main vessel : &gt; = 2.5 mm vessel size , &gt; = 50 % diameter stenosis = &lt; 50 mm lesion length visual estimation , lesion seem cover = &lt; 2 stent Side branch : &gt; = 2.0 mm vessel size , &gt; = 50 % diameter stenosis , &lt; 20 mm lesion length visual estimation , lesion seem cover single stent History bleeding diathesis coagulopathy Pregnant Known hypersensitivity contraindication contrast agent , heparin , sirolimus paclitaxel Limited lifeexpectancy ( less 1 year ) due combine serious disease STelevation acute myocardial infarction &lt; 2 week Characteristics lesion : Left main disease Instent restenosis Graft vessel Chronic total occlusion TIMI flow = &lt; grade 2 side branch Renal dysfunction , creatinine &gt; = 2.0mg/dL Contraindication aspirin , clopidogrel cilostazol LV ejection fraction = &lt; 35 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>stent</keyword>
	<keyword>bifurcation</keyword>
	<keyword>coronary artery stenosis</keyword>
	<keyword>balloon angioplasty</keyword>
</DOC>